Enclosing herewith the press release for repeat order received from one of the India''s leading large network of pharmacies and healthcare company
ORDERS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 13 Jul 2026, 02:53 PM IST · BSE ID: 5a37fb96-fa2d-40de-8702-a24533c65f82
View Original BSE Filing (PDF)
💡
In Simple Terms
Veerhealth Care received a new Rs. 1.11 Crore order for products from a major pharmacy chain, and shared future revenue growth expectations.
🤖 AI Summary
- Veerhealth Care secured a repeat order valued at Rs. 1.11 Crores for haircare and oral care products.
- The order is from a leading large network of pharmacies and healthcare companies in India.
- Execution of the order is scheduled to be completed within 45 days from receipt.
- The company anticipates FY27 total income of Rs. 105 Crores and PAT of Rs. 5-6 Crores.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Repeat Order Value
Rs. 1.11 Crores
Order Execution Timeline
within 45 days
FY27 Projected Total Income
Rs. 105 crores
FY27 Projected PAT
Rs. 5-6 crores
FY28 Projected Total Income
Rs. 156 crores
FY28 Projected PAT
Rs. 9-10 crores
Preferential Allotment Warrants
1,00,00,000
Preferential Issue Price per Warrant
Rs.20.25
FY26 Book Value per share
Rs. 11.46
🏢 How This Affects the Company
This repeat order from a significant client reinforces existing business relationships and contributes to the order pipeline. The company's stated income and PAT projections suggest aggressive growth targets.
The Rs. 1.11 Crores order will contribute to revenue upon execution. The company has approved a preferential issue of 1,00,00,000 warrants at Rs. 20.25 each, aimed at funding expansion and potentially increasing book value per share.
Execution of the order within 45 days necessitates timely manufacturing and delivery capabilities. The preferential allotment funds are intended to support forthcoming expansion.
The reliance on repeat orders from a single client presents concentration risk. Meeting ambitious income and PAT projections will require successful execution of growth strategies and market penetration.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are potentially affected by the company's revenue generation and future growth plans detailed in the filing.
🔍
Management Signal
Management signals intent to expand operations and revenue significantly, supported by capital infusion through a preferential issue.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Order execution confirmation
Q2 FY27 results for revenue performance
Progress on USFDA plant clearance talks
MEDIUM RISK
Reliance on repeat orders and ambitious growth projections carry execution risks.
💡 Investor Takeaway
Veerhealth Care secured a Rs. 1.11 Crores repeat order for haircare and oral care products, executable in 45 days. FY27 income target is Rs. 105 Crores, with PAT of Rs. 5-6 Crores.
⚖️ Strengths & Concerns
✅ Positives
- Secured a repeat order of Rs. 1.11 Crores from a large national pharmacy and healthcare network.
- Projected FY27 total income of Rs. 105 Crores with PAT of Rs. 5-6 Crores, indicating growth ambitions.
⚠️ Concerns
- The company relies on repeat orders from specific large clients, indicating potential client concentration.
- Ambitious income and PAT projections for FY27 and FY28 require substantial revenue growth and margin performance.
📅 Company Track Record
Veerhealth Care has recently secured multiple orders, including Rs. 1.11 Crores (July 11, 2026), Rs. 3.60 Crores (June 10, 2026), Rs. 3.6 Crores (June 9, 2026), and Rs. 2.45 Crores (May 15, 2026).
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the value of the repeat order Veerhealth Care received?
Veerhealth Care received a repeat order worth Rs. 1.11 Crores for haircare and oral care products.
From which client did Veerhealth Care receive this repeat order?
The order is from one of India's leading large network of pharmacies and healthcare companies.
When will Veerhealth Care execute this Rs. 1.11 Crore order?
The company expects to execute the order within 45 days from its receipt.
What are Veerhealth Care's income and PAT projections for FY27?
Veerhealth Care expects total income of Rs. 105 Crores and a Profit After Tax (PAT) of Rs. 5-6 Crores for FY27.
What is the book value per share for Veerhealth Care in FY26?
The Book Value per share for FY26 is Rs. 11.46.
Questions based on this BSE filing only. For information purposes.